e-learning
resources
Virtual 2020
Monday, 07.09.2020
Novel methods, diagnostics and biomarkers of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differentiation of NSCLC patients and healthy controls by a urinary microRNA panel
A. Wilke - Raamsteeboers (Enschede, Netherlands), C. Groothuis-Oudshoorn (Enschede, Netherlands), A. De Moor (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), J. De Rooij (Enschede, Netherlands), E. Citgez (Enschede, Netherlands)
Source:
Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Session:
Novel methods, diagnostics and biomarkers of chronic lung diseases
Session type:
Oral Presentation
Number:
3831
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Wilke - Raamsteeboers (Enschede, Netherlands), C. Groothuis-Oudshoorn (Enschede, Netherlands), A. De Moor (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), J. De Rooij (Enschede, Netherlands), E. Citgez (Enschede, Netherlands). Differentiation of NSCLC patients and healthy controls by a urinary microRNA panel. 3831
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010
Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004
Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Quantitative RT-PCR 3-gene expression signature predicts survival in early-stage non-small cell lung cancer (NSCLC) patients (pts)
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Characteristics and prognostic relevance of
p
53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
The comparison of subsets of blood lymphocytes in patients with lung cancer,COPD,and tuberculosis according to healthy controls
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001
Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Comparison of serum IL-18 levels in tuberculosis with pneumonia, lung cancer and healthy controls
Source: Eur Respir J 2003; 22: Suppl. 45, 340s
Year: 2003
Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005
Analysis and comparison of the transcriptome of COPD patients with and without lung cancer
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
C-erbB-3 expression in non small cell lung cancer (NSCLC) patients treated by erlotinib
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Abnormal expression of let-7a miRNA in blood of lung cancer patient
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Gene expression profiling of induced sputum from COPD patients and healthy smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept